Germline TP53 variants and susceptibility to osteosarcoma.
about
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate TherapiesGermline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.TP53 Mutations and Survival in Osteosarcoma Patients: A Meta-Analysis of Published Data.Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.Biological characterization of soft tissue sarcomasLi-Fraumeni SyndromeAssociation of common variants in MTAP with susceptibility and overall survival of osteosarcoma: a two-stage population-based study in Han Chinese.Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.Genetic factors conferring metastasis in osteosarcoma.The pharmacogenomics of osteosarcoma.Clinical Outcomes of TP53 Mutations in Cancers.Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.WWOX and p53 Dysregulation Synergize to Drive the Development of OsteosarcomaOncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope.Pediatric oncologist willingness to offer germline TP53 testing in osteosarcoma.Current and future therapeutic approaches for osteosarcoma.Advances in the Treatment of Pediatric Bone Sarcomas.Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
P2860
Q26782646-8EC9A244-5686-4BE9-80BC-330551109FD5Q30235105-16B76F51-C95D-4600-AAE7-1B3EE6428C20Q31103785-D7E015AE-1B1C-42C4-A2AB-BE3FF0A56970Q33872384-285B81F8-D89B-42DE-9C9F-87F97AEF7D20Q35770577-60B91CAD-D761-4161-96B5-65C29EA3EB87Q36430658-42A7C0F2-1A22-45B6-9732-3E165590EC11Q37032644-7187452D-D863-4BDA-837B-3945DBE030D9Q37514040-D36AC3D2-FACD-481C-8ABB-EE9BBA769905Q37641721-8723F780-3BD0-409B-977F-5B3A179E653AQ38806986-47BD258B-E17E-42D5-B12B-8FD5E9DF9217Q38848413-9B002FB0-DB0B-4E08-985A-5B2BCE473C86Q38906201-C2E80172-9C2E-461B-B310-1139080DAF36Q39041480-38C0C672-1091-4CD4-BB72-8C69C53B43C7Q42355620-16BDF7CC-433A-4D44-96B9-B61E510112D8Q47095296-15D5D03A-31B1-454B-8027-16F4A2BB173CQ47191921-A0B3FD2F-3372-48F9-B4D5-0236013252D0Q47360357-3E81A51D-0187-406C-9F14-26270557D47EQ50969326-BE9C56EC-F498-4008-BD62-23140852EB4AQ52793910-37ACB03E-3BE9-4099-84FE-A1910AB8E613
P2860
Germline TP53 variants and susceptibility to osteosarcoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Germline TP53 variants and susceptibility to osteosarcoma.
@ast
Germline TP53 variants and susceptibility to osteosarcoma.
@en
type
label
Germline TP53 variants and susceptibility to osteosarcoma.
@ast
Germline TP53 variants and susceptibility to osteosarcoma.
@en
prefLabel
Germline TP53 variants and susceptibility to osteosarcoma.
@ast
Germline TP53 variants and susceptibility to osteosarcoma.
@en
P2093
P2860
P50
P356
P1476
Germline TP53 variants and susceptibility to osteosarcoma
@en
P2093
Aurelie Vogt
Chand Khanna
Donald A Barkauskas
Irene L Andrulis
Jay S Wunder
Joseph F Boland
Julie M Gastier-Foster
Kristine Jones
Lisa Mirabello
Luis Sierrasesúmaga
P2860
P356
10.1093/JNCI/DJV101
P407
P577
2015-04-20T00:00:00Z